APA (7th ed.) Citation

F, Z., RJ, J., L, L., HJ, X., LM, M., Y, Z., . . . WL, L. (2015). Application of functional vincristine plus dasatinib liposomes to deletion of vasculogenic mimicry channels in triple-negative breast cancer. Oncotarget, 6(34), 36625. https://doi.org/10.18632/oncotarget.5382

Chicago Style (17th ed.) Citation

F, Zeng, et al. "Application of Functional Vincristine Plus Dasatinib Liposomes to Deletion of Vasculogenic Mimicry Channels in Triple-negative Breast Cancer." Oncotarget 6, no. 34 (2015): 36625. https://doi.org/10.18632/oncotarget.5382.

MLA (9th ed.) Citation

F, Zeng, et al. "Application of Functional Vincristine Plus Dasatinib Liposomes to Deletion of Vasculogenic Mimicry Channels in Triple-negative Breast Cancer." Oncotarget, vol. 6, no. 34, 2015, p. 36625, https://doi.org/10.18632/oncotarget.5382.

Warning: These citations may not always be 100% accurate.